Clifford Stocks

Clifford Stocks

Chief Executive Officer at OncoResponse
Seattle, Washington, United States

Clifford Stocks is the founder of OncoResponse and currently leads the company. He previously served as Executive Officer and Director at OncoResponse Inc.

Recent coverage

Front-page news, podcasts and videos about Clifford

See all 4

OncoResponse raises $40M Series B to advance five antibody-based cancer immunotherapies into preclinical and clinical trials

OncoResponse raised $40 million in a Series B to push five antibody-based cancer immunotherapy candidates into preclinical and clinical studies, bringing total funding to nearly $70 million since its 2015 launch. The company mines antibodies from cancer patients who had exceptional responses to immunotherapy to develop treatments that modulate tumor‑microenvironment immunosuppression.

Organizations

See all 6
  • OncoResponse Executive Officer, Director 2017–present, Chief Executive Officer 2015–present · current
  • Theraclone Sciences Chief Executive Officer 2011–2016 · past
  • Calistoga Pharmaceuticals (acquired by Gilead 2011) Chief Business Officer 2009–2011 · past

Education

  • The University of Chicago Booth School of Business MBA, Statistics; Operations; Leadership · 1986–1989
  • University of Utah B.S., Biology · 1976–1980

Online

Questions about Clifford Stocks

Who is Clifford Stocks?

Clifford Stocks is Chief Executive Officer at OncoResponse.

Which organizations is Clifford Stocks associated with?

On Seattle Flow, Clifford Stocks is listed with OncoResponse, Theraclone Sciences, Calistoga Pharmaceuticals (acquired by Gilead 2011) and 3 more.

Where did Clifford Stocks study?

Clifford Stocks studied at The University of Chicago Booth School of Business and University of Utah.

Where is Clifford Stocks based?

Clifford Stocks is based in Seattle, Washington, United States.

Where can I find Clifford Stocks online?

Clifford Stocks is on LinkedIn and X.